Arcadia Cash And Short Term Investments from 2010 to 2024

RKDA Stock  USD 2.93  0.06  2.01%   
Arcadia Biosciences' Cash And Short Term Investments are increasing over the years with stable fluctuation. Cash And Short Term Investments are expected to dwindle to about 11.1 M. Cash And Short Term Investments is the sum of a company's cash on hand, including bank deposits and short-term, highly liquid investments that are easily convertible to known amounts of cash. View All Fundamentals
 
Cash And Short Term Investments  
First Reported
2013-12-31
Previous Quarter
11.6 M
Current Value
8.5 M
Quarterly Volatility
17.7 M
 
Yuan Drop
 
Covid
Check Arcadia Biosciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Arcadia Biosciences' main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.6 M, Interest Expense of 247.1 K or Selling General Administrative of 14.7 M, as well as many indicators such as Price To Sales Ratio of 0.69, Dividend Yield of 0.0 or PTB Ratio of 0.32. Arcadia financial statements analysis is a perfect complement when working with Arcadia Biosciences Valuation or Volatility modules.
  
Check out the analysis of Arcadia Biosciences Correlation against competitors.
For information on how to trade Arcadia Stock refer to our How to Trade Arcadia Stock guide.

Latest Arcadia Biosciences' Cash And Short Term Investments Growth Pattern

Below is the plot of the Cash And Short Term Investments of Arcadia Biosciences over the last few years. Short Term Investments is an account in the current assets section of Arcadia Biosciences balance sheet. This account contains Arcadia Biosciences investments that will expire within one year. These investments include stocks and bonds that can be liquidated by Arcadia Biosciences fairly quickly. It is the sum of a company's cash on hand, including bank deposits and short-term, highly liquid investments that are easily convertible to known amounts of cash. Arcadia Biosciences' Cash And Short Term Investments historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Arcadia Biosciences' overall financial position and show how it may be relating to other accounts over time.
Cash And Short Term Investments10 Years Trend
Pretty Stable
   Cash And Short Term Investments   
       Timeline  

Arcadia Cash And Short Term Investments Regression Statistics

Arithmetic Mean19,608,993
Geometric Mean14,478,255
Coefficient Of Variation76.31
Mean Deviation11,425,473
Median16,571,000
Standard Deviation14,963,514
Sample Variance223.9T
Range47.7M
R-Value0.22
Mean Square Error229.4T
R-Squared0.05
Significance0.43
Slope736,858
Total Sum of Squares3134.7T

Arcadia Cash And Short Term Investments History

202411.1 M
202311.6 M
202220.6 M
202128.7 M
202025.7 M
201925.3 M
201821.8 M

About Arcadia Biosciences Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Arcadia Biosciences income statement, its balance sheet, and the statement of cash flows. Arcadia Biosciences investors use historical funamental indicators, such as Arcadia Biosciences's Cash And Short Term Investments, to determine how well the company is positioned to perform in the future. Although Arcadia Biosciences investors may use each financial statement separately, they are all related. The changes in Arcadia Biosciences's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Arcadia Biosciences's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Arcadia Biosciences Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Arcadia Biosciences. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Cash And Short Term Investments11.6 M11.1 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Information and Resources on Investing in Arcadia Stock

When determining whether Arcadia Biosciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Arcadia Biosciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Arcadia Biosciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Arcadia Biosciences Stock:
Check out the analysis of Arcadia Biosciences Correlation against competitors.
For information on how to trade Arcadia Stock refer to our How to Trade Arcadia Stock guide.
You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Is Agricultural Products & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Arcadia Biosciences. If investors know Arcadia will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Arcadia Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.63)
Earnings Share
(1.77)
Revenue Per Share
3.932
Quarterly Revenue Growth
0.019
Return On Assets
(0.34)
The market value of Arcadia Biosciences is measured differently than its book value, which is the value of Arcadia that is recorded on the company's balance sheet. Investors also form their own opinion of Arcadia Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Arcadia Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Arcadia Biosciences' market value can be influenced by many factors that don't directly affect Arcadia Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Arcadia Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Arcadia Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Arcadia Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.